GlassScriptPhysician profile
Michael Watts
NPI 1528582277
$6,014.59
in general payments reported to CMS, 2019-2025
16 companies · $2,366 in 2025
The $2,366 reported for 2025 was more than what 96% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $520 · 2022: $574 · 2023: $1,051 · 2024: $1,504 · 2025: $2,366.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,601 · Consulting Fee: $1,425 · Travel and Lodging: $895.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,600.87 |
| Consulting Fee | $1,425.00 |
| Travel and Lodging | $894.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,230.32 | 2021-2025 | Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit |
| Philips North America LLC | $894.96 | 2024 | (6578) Visions 018 |
| Novartis Pharmaceuticals Corporation | $819.59 | 2021-2025 | |
| Cvrx, INC. | $347.28 | 2023-2025 | Barostim Neo System |
| Alnylam Pharmaceuticals INC. | $159.71 | 2021-2024 | Amvuttra, Onpattro |
| Merck Sharp & Dohme LLC | $115.28 | 2021-2023 | Verquvo |
| Pfizer INC. | $86.20 | 2021-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $70.02 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $64.32 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $54.66 | 2021-2022 | |
| Kiniksa Pharmaceuticals, LTD. | $48.04 | 2022-2023 | Arcalyst |
| Novo Nordisk INC | $43.68 | 2023-2025 | Ozempic, Rybelsus |
| Bayer Healthcare Pharmaceuticals INC. | $24.08 | 2022 | |
| Atricure, INC. | $22.38 | 2025 | Synergy Ablation System |
| La Jolla Pharmaceutical Company | $20.39 | 2023 | Giapreza |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $13.68 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Watts listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.